EUVIMEDOpdag EUVIMED
EditorialOpen access · CC BY 4.0

Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script

Ralf Weiskirchen

Frontiers in Bioscience-Landmark · 2026-05-21 · 31 (5)

DOI: 10.31083/fbl52945 ↗

At a glance

Editorial in Frontiers in Bioscience-Landmark, published online on 2026-05-21. Written by Ralf Weiskirchen. Institution: Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aache…. 20 references. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Authors and institutions

  • Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, D-52074 Aachen, Germany.

Cite

APA

Weiskirchen, R. (2026). Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script. Frontiers in Bioscience-Landmark, 31(5). https://doi.org/10.31083/fbl52945

Vancouver

Weiskirchen R. Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script. Frontiers in Bioscience-Landmark. 2026;31(5). doi:10.31083/fbl52945

BibTeX
@article{Weiskirchen2026,
  author = {Weiskirchen, Ralf},
  title = {Oxidants at the Epigenetic Crossroads: How Chronic Inflammation Writes the Cancer Script},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {5},
  doi = {10.31083/fbl52945}
}
Start for free →